News for Good Works II Acquisition Corp. (GWII)

NEW YORK, Oct. 17, 2022 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or... | October 17, 2022

SPAC Good Works II Acquisition Corp. (GWII) has signed a letter of intent to merge with Direct Biologics in a deal that pegs the enterprise value of the company at $675M.

HOUSTON & AUSTIN, Texas, September 27, 2022--Good Works II Acquisition Corp. (Nasdaq: GWII) ("Good Works II"), a publicly traded special purpose acquisition company ("SPAC"), and Direct Biologics, LLC ("Direct Biologics"), a late-stage biotechnology company, today announced the signing of a letter of intent for a potential business combination. The letter of intent is non-binding except with respect to certain specified provisions relating to, among other things, exclusivity, expenses and other

Read Short Interest in Good Works II Acquisition Corp. (NASDAQ:GWII) Declines By 6.3% at ETF Daily News

Read Good Works II Acquisition Corp. (NASDAQ:GWII) Shares Sold by Wolverine Asset Management LLC at ETF Daily News

Read Tuttle Capital Management LLC Has $854,000 Position in Good Works II Acquisition Corp. (NASDAQ:GWII) at ETF Daily News

Read Good Works II Acquisition Corp. (NASDAQ:GWII) Sees Significant Decline in Short Interest at ETF Daily News

Read Good Works II Acquisition Corp. (NASDAQ:GWII) Short Interest Down 16.1% in May at ETF Daily News

Read Short Interest in Good Works II Acquisition Corp. (NASDAQ:GWII) Grows By 32.9% at ETF Daily News

Read Good Works II Acquisition Corp. (NASDAQ:GWII) Short Interest Up 22.8% in April at ETF Daily News

GuruFocus Article or News written by insider and the topic is about: